Acrylamide neuropathy I. Spatiotemporal characteristics of nerve cell damage in rat cerebellum

NeuroToxicology

Volumn 23, Issue 3, 2002, Pages 397-414

  Lehning, E J ^a   Balaban, C D ^b   Ross, J F ^c   Reid, M A ^a   LoPachin, R M ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b University of Pittsburgh School of Medicine   (United States)

^c Health and Environ Safety Alliance   (United States)

Author keywords

Neurodegeneration; Neurotoxicant; Neurotoxicity; Purkinje cell; Toxic axonopathy

Indexed keywords

ACRYLAMIDE; COPPER DERIVATIVE; SILVER;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARGYROPHILIA; ARTICLE; BRAIN STEM; CEREBELLUM; CONTROLLED STUDY; EFFERENT NERVE; MALE; NERVE CELL DEGENERATION; NERVE CELL LESION; NERVE FIBER DEGENERATION; NEUROPATHY; NEUROTOXICITY; NONHUMAN; PERIKARYON; PRIORITY JOURNAL; PURKINJE CELL; RAT;

NON-PROGRAMMATIC;

ACRYLAMIDE; ANIMALS; AXONS; BODY WEIGHT; CALCIUM-BINDING PROTEIN, VITAMIN D-DEPENDENT; CASPASE 3; CASPASES; CELL COUNT; CEREBELLAR CORTEX; CEREBELLUM; COLORING AGENTS; COPPER; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; MALE; NERVE DEGENERATION; NERVOUS SYSTEM DISEASES; NEURONS; PURKINJE CELLS; RATS; RATS, SPRAGUE-DAWLEY; SILVER STAINING; TIME FACTORS;

EID: 0036745168     PISSN: 0161813X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-813X(02)00083-9     Document Type: Article

References (53)

1. Angner RT, Kelly RM, Wiley RG, Walsh TJ, Reuhl KR. Preferential destruction of cerebellar Purkinje cells by OX7-saporin. NeuroToxicology 2000;21:395-404.
2. Balaban CD. Olivovestibular and cerebellovestibular connections in albino rabbits. Neuroscience 1984;12:129-49.
3. Balaban CD. The use of selective silver degeneration stains in neurotoxicology. In: Isaacson RL, Jensen KF, editors. The vulnerable brain and environmental risks, vol. 1. Malnutrition and hazard assessment. New York: Plenum Press, 1992. p. 223-38.
4. Barber DS, Hunt JR, Ehrich MF, Lehning EJ, LoPachin RM. Metabolism, toxicokinetics and hemoglobin adduct formation in rats following subacute and subchronic acrylamide dosing. NeuroToxicology 2001;22:341-53.
5. Burgess DL, Kohrman DC, Galt J, Plummer NW, Jones JM, Spear B, Meisler MH. Mutation of a new sodium channel gene, Scn8a, in the mouse mutant motor endplate disease. Nat Genet 1995;10:461-5.
6. Cavanagh JB. The significance of the dying-back process in experimental and human neurological disease. Int Rev Exp Pathol 1964;3:219-67.
7. Cavanagh JB. The dying-back process. Arch Pathol Lab Med 1979;103:659-64.
8. Cavanagh JB. The pathokinetics of acrylamide intoxication: a reassessment of the problem. Neuropathol Appl Neurobiol 1982;8:315-36.
9. Cavanagh JB, Nolan CC. Selective loss of Purkinje cells from the rat cerebellum caused by acrylamide and the responses of β-glucuronidase and β-galactosidase. Acta Neuropathol 1982;58:210-4.
10. Cavanagh JB, Gysbers MF. Ultrastructural features of the Purkinje cell damage caused by acrylamide in the rat: a new phenomenon in cellular neuropathology. J Neurocytol 1983;12:413-37.
11. Chan-Palay V, Nilaver G, Palay SL, Beinfeld MC, Zimmerman EA, Wu JY. Chemical heterogeneity in cerebellar PCs: existence and coexistence of glutamic acid decarboxylase-like immunoreactivities. Proc Natl Acad Sci USA 1981;78:7787-91.
12. Crofton KM, Padilla S, Tilson HA, Anthony DC, Raymer JH, MacPhail RC. The impact of dose-rate on the neurotoxicity of acrylamide: the interaction of administered dose, target tissue concentrations, tissue damage, and functional effects. Toxicol Appl Pharmacol 1996;139:163-76.
13. de Olmos JS, Ebbesson SOE, Heimer L. Silver methods for the impregnation of degenerating axoplasm. In: Heimer L, Robards MJ, editors. Neuroanatomical tract-tracing methods. New York: Plenum Press, 1981. p. 117-70.
14. de Olmos JS, Beltramino CA, de Lorenzo de Olmos S. Use of an amino-cupric-silver technique for the detection of early and semiacute neuronal degeneration caused by neurotoxicants, hypoxia and physical trauma. Neurotoxicol Teratol 1994;16:545-61.
15. Dick DJ, Boakes RJ, Harris JB. A cerebellar abnormality in the mouse with motor end-plate disease. Neuropathol Appl Neurobiol 1985;11:141-7.
16. Fix AS, Ross JF, Stitzel SR, Switzer RC. Integrated evaluation of central nervous system lesions: stains for neurons, astrocytes and microglia reveal the spatial and temporal features of MK-801-induced neuronal necrosis in the rat cerebral cortex. Toxicol Pathol 1996;24:291-304.
17. Fix AS, Stitzel SR, Ridder GM, Switzer RC. MK-801 neurotoxicity in cupric-silver-stained sections: lesion reconstruction by three-dimentional computer image analysis. Toxicol Pathol 2000;28:84-90.
18. Ghez C, Thach WT. The cerebellum. In: Kandel ER, Schwartz JH, Jessell TM, editors. Principles of neural science. 4th ed. New York: McGraw-Hill, 2000. p. 832-52.
19. Gold BG, Schaumburg HH. Acrylamide. In: Spencer PS, Schaumburg HH, Ludolph AC, editors. Experimental and clinical neurotoxicology. 2nd ed. New York: Oxford University Press, 2000. p. 124-32.
20. Hawkes R, Gravel C. The modular cerebellum. Prog Neurobiol 1991;36:309-27.
21. Ito M. The cerebellum and neural control. New York: Raven Press, 1984.
22. Kuperman AS. Effects of acrylamide on the central nervous system of the cat. J Pharmacol Exp Ther 1958;123:180-92.
23. Lehning EJ, Persaud A, Dyer KR, Jortner BS, LoPachin RM. Biochemical and morphologic characterization of acrylamide peripheral neuropathy. Toxicol Appl Pharmacol 1998;151:211-21.
24. Lehning EJ, Balaban CD, Ross JF, LoPachin RM. Acrylamide neuropathy. II. Spatiotemporal characteristics of nerve cell damage in rat brainstem and spinal cord. NeuroToxicology, 2002a;23:417-31.
25. Lehning EJ, Balaban CD, Ross JF, LoPachin RM. Acrylamide neuropathy. III. Spatiotemporal characteristics of nerve cell damage in rat forebrain. NeuroToxicology, 2002b [submitted for publication].
26. LeQuesne PM. Acrylamide. In: Spencer PS, Schaumburg HH, editors. Experimental and clinical neurotoxicology, 1st ed. Baltimore, MD: Williams and Wilkins, 1980. p. 309-25.
27. LeQuesne PM. Clinical and morphological findings in acrylamide toxicity. NeuroToxicology 1985;6:17-24.
28. LoPachin RM, Lehning EJ. Acrylamide-induced distal axon degeneration: a proposed mechanism of action. NeuroToxicology 1994;15:247-60.
29. LoPachin RM, Lehning EJ, Opanashuk LA, Jortner BS. Rate of neurotoxicant exposure determines morphologic manifestations of distal axonopathy. Toxicol Appl Pharmacol 2000;167:75-86.
30. LoPachin RM, Ross JF, Lehning EJ. Nerve terminals as the primary site of acrylamide action: a hypothesis. NeuroToxicology, 2002a;23:43-59.
31. LoPachin RM, Ross JF, Reid ML, Dasgupta S, Mansukhani S, Lehning EJ. Neurological evaluation of toxic axonopathies in rats: acrylamide and 2, 5-hexanedione. NeuroToxicology, 2002b;23:95-110.
32. Marani E, Voogd J. Some aspects of the localization of the enzyme 5′-nucleotidas in the molecular layer of the cerebellum of the mouse. Acta Morphol Neerl Scand 1973;11:353-4.
33. Marani E, Voogd J. An acetylcholinesterase band pattern in the molecular layer of the cerebellum of the cat. J Anat 1977;124:335-45.
34. Paxinos G, Watson C. The rat brain in stereotaxic coordinates. 4th ed. New York: Academic Press, 1998.
35. Rossi F, Borsello T, Strata P. Exposure to kainic acid mimics the effects of axotomy in cerebellar Purkinje cells of the adult rat. Eur J Neurosci 1994;6:392-402.
36. Rossi F, Jankovski A, Sotelo C. Target neuron controls the integrity of afferent axon phenotype: a study on the Purkinje cell-climbing fiber system in cerebellar mutant mice. J Neurosci 1995;15:2040-56.
37. Sotelo C. Axonal abnormalities in cerebellar Purkinje cells of the hyperspiny Purkinje cell mutant mouse. J Neurocytol 1990;19:737-55.
38. Spencer PS, Schaumburg HH. A review of acrylamide neurotoxicity. Part I. Properties, uses and human exposure. Can J Neurol Sci 1974a;1:151-69.
39. Spencer PS, Schaumburg HH. A review of acrylamide neurotoxicity. Part II. Experimental animal neurotoxicity and pathologic mechanisms. Can J Neurol Sci 1974b;1:170-92.
40. Spencer PS, Schaumburg HH. Central-peripheral distal axonopathy-the pathology of dying-back polyneuropathies. In: Zimmerman H, editor. Progress in neuropathology, vol. 3. New York: Grune & Stratton, 1976. p. 253-76.
41. Spencer PS, Schaumburg HH. Ultrastructural studies of the dying-back process. III. The evolution of experimental peripheral giant axonal degeneration. J Neuropathol Exp Neurol 1977a;36:276-99.
42. Spencer PS, Schaumburg HH. Ultrastructural studies of the dying-back process. IV. Differential vulnerability of PNS and CSN fibers in experimental central-peripheral distal axonopathies. J Neuropathol Exp Neurol 1977b;36:300-20.
43. Spencer PS, Schaumburg HH. Pathobiology of neurotoxic axonal degeneration. In: Waxman SG, editor. Physiology and pathobiology of axons. New York: Raven Press, 1978. p. 265-82.
44. Spencer PS, Schaumburg HH. Classification of neurotoxic disease: a morphological approach. In: Spencer PS, Schaumburg HH, editor. Experimental and clinical neurotoxicology. Baltimore: Williams and Wilkins, 1980. p. 92-9.
45. Switzer RC. Application of silver degeneration stains for neurotoxicity testing. Toxicol Pathol 2000;28:70-83.
46. Tilson HA. The neurotoxicity of acrylamide: an overview. Neurobehav Toxicol Teratol 1981;3:445-61.
47. Umetani T. Efferent projections from the flocculus in the albino rat as revealed by an autoradiographic orthograde tracing method. Brain Res 1992;586:91-103.
48. US Environmental Protection Agency. Toxic Substance Control Act Testing Guidelines. Federal Register, vol. 50, 40 CFR, Part 798, Subpart G. no. 188, 1985.
49. US Environmental Protection Agency. Preliminary assessment of health risks from exposure to acrylamide. Washington, DC: Office of Toxic Substances, US Environmental Protection Agency, 1988.
50. Victor M, Adams RD, Mancall EL. A restricted form of cerebellar cortical degeneration occurring in alcoholic patients. AMA Arch Neurol 1959;1:579-688.
51. Voogd J. Cerebellum. In: Paxinos G, editor. The rat nervous system. 2nd ed. New York: Academic Press, 1995. p. 309-52.
52. Wassef M, Sotelo C, Cholley B, Brehier A, Thomasset M. Cerebellar mutations affecting the postnatal survival of Purkinje cells in the mouse disclose a longitudinal pattern of differentially sensitive cells. Dev Biol 1987;124:379-89.
53. Xiong G, Matsushita M. Connections of Purkinje cell axons of lobule X with vestibulocerebellar neurons projecting to lobule X or IX in the rat. Exp Brain Res 2000;133:219-28.